Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan Multinational Trial Organisation LC00-03
Top Cited Papers
- 24 February 2009
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 45 (11), 1950-1958
- https://doi.org/10.1016/j.ejca.2009.01.023
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, phase III studyThe Lancet Oncology, 2008
- Cancer-related inflammationNature, 2008
- Relationship between Response and Survival in More Than 50,000 Patients with Advanced Non-small Cell Lung Cancer Treated with Systemic Chemotherapy in 143 Phase III TrialsJournal of Thoracic Oncology, 2007
- The Baseline Ratio of Neutrophils to Lymphocytes Is Associated with Patient Prognosis in Advanced Gastric CancerOncology, 2007
- Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancerJournal of Surgical Oncology, 2005
- Inflammation and cancerNature, 2002
- Establishment of a Clonal Cell Line Producing Granulocyte Colony‐Stimulating Factor and Parathyroid Hormone‐Related Protein from a Lung Cancer Patient with Leukocytosis and HypercalcemiaJapanese Journal of Cancer Research, 1996
- Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic FactorsJNCI Journal of the National Cancer Institute, 1994
- Kinetics of human hemopoietic cells after in vivo administration of granulocyte-macrophage colony-stimulating factor.Journal of Clinical Investigation, 1989
- Tumors: Wounds That Do Not HealNew England Journal of Medicine, 1986